IPO registrations (S-1, F-1) · Registrants
Alector, Inc.
- SEC CIK
- 1653087 · filings on EDGAR ↗
- Former names
- Alector LLC (2015–2015)
- Registration
- Form S-1, first filed 2019-01-07, last 2020-01-29; 2 initial registrations, 3 amendments
- Outcome
- Final prospectus filed 2019-02-07; declared effective 2019-02-06
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, South San Francisco, CA 94080
- EIN
- 82-2933343
- Ticker
- ALEC (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Alector, Inc. on the corporate pages
Offering terms
- Proposed price range
- $18.00–$20.00 per share (S-1/A filed 2019-02-06)
- Final price
- $19.00 per share, within the range (424B4 filed 2019-02-07, an initial public offering)
- Shares sold
- 9,250,000
- Gross proceeds
- $175,750,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol ALEC
- Lead underwriters
- Morgan Stanley; Cowen (1,850,000 shares); Barclays (1,480,000 shares); Merrill Lynch (2,775,000 shares)
- Syndicate
- BofA Securities
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: ALECTOR, INC. Fuzzy (name and state)
- Business registration: ALECTOR LLC Fuzzy (name and state)
- Federal award recipient: ALECTOR, LLC Fuzzy (name and state)
- Form D issuer: Alector LLC EXACT (CIK (EXACT))
- SEC filer: Alector, Inc. EXACT (CIK (EXACT))
Filings 10
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2019-01-07 | S-1 | S-1 (registration) | Alector, Inc. | 0001193125-19-003772 ↗ |
| 2019-01-29 | S-1/A | S-1/A (amendment) | Alector, Inc. | 0001193125-19-019648 ↗ |
| 2019-02-06 | S-1/A | S-1/A (amendment) | Alector, Inc. | 0001193125-19-029514 ↗ |
| 2019-02-06 | EFFECT | EFFECT (declared effective) | Alector, Inc. | 9999999995-19-000107 ↗ |
| 2019-02-07 | 424B4 | 424B4 (final prospectus) | Alector, Inc. | 0001193125-19-030566 ↗ |
| 2020-01-27 | S-1 | S-1 (registration) | Alector, Inc. | 0001193125-20-015336 ↗ |
| 2020-01-29 | S-1/A | S-1/A (amendment) | Alector, Inc. | 0001193125-20-017882 ↗ |
| 2020-01-29 | S-1MEF | S-1MEF (added securities) | Alector, Inc. | 0001193125-20-018822 ↗ |
| 2020-01-29 | EFFECT | EFFECT (declared effective) | Alector, Inc. | 9999999995-20-000190 ↗ |
| 2020-01-30 | 424B4 | 424B4 (final prospectus) | Alector, Inc. | 0001193125-20-019151 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2019-02-06 | S-1/A | registration statement | $18.00–$20.00 | 9,250,000 | - | Nasdaq ALEC | 5 | primary document; range, shares headline, cover names 4 | document ↗ | |
| 2019-02-07 | 424B4 | final prospectus | $19.00 | 9,250,000 | $175,750,000 | Nasdaq ALEC | 5 | primary document; price sentence, shares headline, proceeds table, underwriting table 3, cover names 4 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Gerngross Tillman U. | Director | 7 | 2019–2023 | ||
| GORDON CARL L | Director,TenPercentOwner | 3 | 2019 | ||
| King Robert | Officer | Chief Development Officer | 17 | 2019–2022 | |
| LAVIGNE LOUIS J JR | Director | 10 | 2019–2026 | ||
| MCGUIRE TERRANCE | Director; Director,TenPercentOwner | 12 | 2019–2023 | ||
| Oney Sabah | Officer | Chief Business Officer | 10 | 2019–2020 | |
| ORBIMED ADVISORS LLC | Director,TenPercentOwner; TenPercentOwner | 11 | 2019–2020 | ||
| OrbiMed Capital GP IV LLC | Director,TenPercentOwner; TenPercentOwner | 11 | 2019–2020 | ||
| Paul Robert | Officer | Chief Medical Officer | 35 | 2019–2021 | |
| Polaris Venture Management Co. VI, L.L.C. | TenPercentOwner | 9 | 2019–2024 | ||
| Polaris Venture Partners Founders' Fund VI, L.P. | TenPercentOwner | 9 | 2019–2024 | ||
| Polaris Venture Partners VI (AIV-B), L.P. | TenPercentOwner | 9 | 2019–2024 | ||
| Polaris Venture Partners VI (AIV), L.P. | TenPercentOwner | 9 | 2019–2024 | ||
| Polaris Venture Partners VI, L.P. | TenPercentOwner | 9 | 2019–2024 | ||
| Rosenthal Arnon | Director,Officer | Chief Executive Officer | 33 | 2019–2026 | |
| SCHELLER RICHARD H | Director | 17 | 2019–2026 | ||
| Wehner David M. | Director | 9 | 2019–2024 | ||
| Yu Calvin | Officer | Vice President, Finance | 10 | 2019–2021 | |
| ORBIMED CAPITAL LLC | Director,TenPercentOwner; TenPercentOwner | 6 | 2019–2020 | ||
| Yaffe Kristine | Director | 12 | 2019–2026 | ||
| SULIMAN SHEHNAAZ | Officer | President and COO | 6 | 2019–2021 | |
| Hammond Paula | Director | 10 | 2020–2026 | ||
| Rubinstein Linda M | Officer | Interim Chief Financial Ofcr | 1 | 2021 | |
| GAROFALO ELIZABETH A. | Director | 8 | 2021–2026 | ||
| Kenkare-Mitra Sara | Officer | President and Head of R&D | 18 | 2021–2025 | |
| GRASSO MARC | Officer | Chief Financial Officer | 15 | 2022–2025 | |
| Romano Gary | Officer | Chief Medical Officer | 15 | 2022–2025 | |
| Altmeyer Mark | Director | 4 | 2024–2026 | ||
| DESOUZA ERROL B | Director | 4 | 2024–2026 | ||
| Berkley Neil Lindsay | Officer | CFO & Chief Business Officer; Chief Bus Ofcr & Interim CFO; Principal Financial Officer | 9 | 2025–2026 | |
| Wong-Sarad Grace | Officer | Principal Accounting Officer | 13 | 2025–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2015-09-16 | Alector LLC | Biotechnology | $32,275,003 | $32,275,003 | 11 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | Alector LLC | CA | Form D private offerings | CIK (EXACT) |
| SEC filer | Alector, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Business registration | ALECTOR, INC. | State business registries | name and state | |
| Business registration | ALECTOR LLC | State business registries | name and state | |
| Federal award recipient | ALECTOR, LLC | Federal spending (USAspending) | name and state |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.